vs
Encompass Health Corp（EHC）与罗致恒富（RHI）财务数据对比。点击上方公司名可切换其他公司
Encompass Health Corp的季度营收约是罗致恒富的1.2倍（$1.5B vs $1.3B），Encompass Health Corp同比增速更快（9.9% vs -5.8%），罗致恒富自由现金流更多（$170.8M vs $116.7M），过去两年Encompass Health Corp的营收复合增速更高（8.3% vs -6.1%）
Encompass Health Corp前身为Amcare及HealthSouth，总部位于美国阿拉巴马州伯明翰，是美国规模最大的住院康复服务提供商，在39个州及波多黎各拥有173家住院康复医院，为中风、神经系统疾病、心肺病症、脑损伤等患者提供专业康复诊疗服务。
罗致恒富是1948年成立的国际人力资源咨询机构，总部位于加利福尼亚州门洛帕克和圣拉蒙，是全球规模领先的会计与金融领域人才派遣服务商之一，在全球范围内设有超过345个办公点。
EHC vs RHI — 直观对比
营收规模更大
EHC
是对方的1.2倍
$1.3B
营收增速更快
EHC
高出15.7%
-5.8%
自由现金流更多
RHI
多$54.1M
$116.7M
两年增速更快
EHC
近两年复合增速
-6.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.3B |
| 净利润 | $146.1M | — |
| 毛利率 | — | 37.6% |
| 营业利润率 | 16.7% | 1.7% |
| 净利率 | 9.5% | — |
| 营收同比 | 9.9% | -5.8% |
| 净利润同比 | 20.8% | — |
| 每股收益（稀释后） | $1.43 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EHCRHI
| Q4 25 | $1.5B | $1.3B | ||
| Q3 25 | $1.5B | $1.4B | ||
| Q2 25 | $1.5B | $1.4B | ||
| Q1 25 | $1.5B | $1.4B | ||
| Q4 24 | $1.4B | $1.4B | ||
| Q3 24 | $1.4B | $1.5B | ||
| Q2 24 | $1.3B | $1.5B | ||
| Q1 24 | $1.3B | $1.5B |
净利润EHCRHI
| Q4 25 | $146.1M | — | ||
| Q3 25 | $126.5M | $42.9M | ||
| Q2 25 | $142.1M | $41.0M | ||
| Q1 25 | $151.5M | $17.4M | ||
| Q4 24 | $120.9M | — | ||
| Q3 24 | $108.2M | $65.5M | ||
| Q2 24 | $114.1M | $68.2M | ||
| Q1 24 | $112.5M | $63.7M |
毛利率EHCRHI
| Q4 25 | — | 37.6% | ||
| Q3 25 | — | 37.2% | ||
| Q2 25 | — | 37.2% | ||
| Q1 25 | — | 36.9% | ||
| Q4 24 | — | 38.8% | ||
| Q3 24 | — | 39.0% | ||
| Q2 24 | — | 39.2% | ||
| Q1 24 | — | 38.1% |
营业利润率EHCRHI
| Q4 25 | 16.7% | 1.7% | ||
| Q3 25 | 14.9% | 1.0% | ||
| Q2 25 | 16.2% | 0.1% | ||
| Q1 25 | 16.4% | 2.9% | ||
| Q4 24 | 14.3% | 4.7% | ||
| Q3 24 | 13.6% | 4.1% | ||
| Q2 24 | 14.3% | 5.1% | ||
| Q1 24 | 13.6% | 2.8% |
净利率EHCRHI
| Q4 25 | 9.5% | — | ||
| Q3 25 | 8.6% | 3.2% | ||
| Q2 25 | 9.7% | 3.0% | ||
| Q1 25 | 10.4% | 1.3% | ||
| Q4 24 | 8.6% | — | ||
| Q3 24 | 8.0% | 4.5% | ||
| Q2 24 | 8.8% | 4.6% | ||
| Q1 24 | 8.5% | 4.3% |
每股收益（稀释后）EHCRHI
| Q4 25 | $1.43 | $0.32 | ||
| Q3 25 | $1.24 | $0.43 | ||
| Q2 25 | $1.39 | $0.41 | ||
| Q1 25 | $1.48 | $0.17 | ||
| Q4 24 | $1.18 | $0.53 | ||
| Q3 24 | $1.06 | $0.64 | ||
| Q2 24 | $1.12 | $0.66 | ||
| Q1 24 | $1.10 | $0.61 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.2M | $464.4M |
| 总债务越低越好 | $2.4B | — |
| 股东权益账面价值 | $2.4B | $1.3B |
| 总资产 | $7.1B | $2.9B |
| 负债/权益比越低杠杆越低 | 1.00× | — |
8季度趋势，按日历期对齐
现金及短期投资EHCRHI
| Q4 25 | $72.2M | $464.4M | ||
| Q3 25 | $48.7M | $365.3M | ||
| Q2 25 | $99.1M | $380.5M | ||
| Q1 25 | $95.8M | $342.5M | ||
| Q4 24 | $85.4M | $537.6M | ||
| Q3 24 | $147.8M | $570.5M | ||
| Q2 24 | $154.4M | $547.4M | ||
| Q1 24 | $134.4M | $540.9M |
总债务EHCRHI
| Q4 25 | $2.4B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.4B | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.7B | — |
股东权益EHCRHI
| Q4 25 | $2.4B | $1.3B | ||
| Q3 25 | $2.4B | $1.3B | ||
| Q2 25 | $2.3B | $1.3B | ||
| Q1 25 | $2.2B | $1.3B | ||
| Q4 24 | $2.1B | $1.4B | ||
| Q3 24 | $2.0B | $1.5B | ||
| Q2 24 | $1.8B | $1.5B | ||
| Q1 24 | $1.7B | $1.5B |
总资产EHCRHI
| Q4 25 | $7.1B | $2.9B | ||
| Q3 25 | $6.9B | $2.8B | ||
| Q2 25 | $6.8B | $2.8B | ||
| Q1 25 | $6.6B | $2.7B | ||
| Q4 24 | $6.5B | $2.9B | ||
| Q3 24 | $6.5B | $3.0B | ||
| Q2 24 | $6.4B | $2.9B | ||
| Q1 24 | $6.2B | $2.9B |
负债/权益比EHCRHI
| Q4 25 | 1.00× | — | ||
| Q3 25 | 1.01× | — | ||
| Q2 25 | 1.02× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.14× | — | ||
| Q3 24 | 1.20× | — | ||
| Q2 24 | 1.46× | — | ||
| Q1 24 | 1.54× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $346.0M | $182.5M |
| 自由现金流经营现金流 - 资本支出 | $116.7M | $170.8M |
| 自由现金流率自由现金流/营收 | 7.6% | 13.1% |
| 资本支出强度资本支出/营收 | 14.8% | 0.9% |
| 现金转化率经营现金流/净利润 | 2.37× | — |
| 过去12个月自由现金流最近4个季度 | $439.2M | $266.8M |
8季度趋势，按日历期对齐
经营现金流EHCRHI
| Q4 25 | $346.0M | $182.5M | ||
| Q3 25 | $270.8M | $77.4M | ||
| Q2 25 | $270.2M | $119.4M | ||
| Q1 25 | $288.6M | $-59.3M | ||
| Q4 24 | $278.8M | $154.8M | ||
| Q3 24 | $267.8M | $129.6M | ||
| Q2 24 | $217.4M | $142.0M | ||
| Q1 24 | $238.8M | $-15.9M |
自由现金流EHCRHI
| Q4 25 | $116.7M | $170.8M | ||
| Q3 25 | $83.7M | $63.6M | ||
| Q2 25 | $113.3M | $104.2M | ||
| Q1 25 | $125.5M | $-71.7M | ||
| Q4 24 | $80.1M | $140.5M | ||
| Q3 24 | $120.3M | $111.8M | ||
| Q2 24 | $60.5M | $129.6M | ||
| Q1 24 | $99.4M | $-27.7M |
自由现金流率EHCRHI
| Q4 25 | 7.6% | 13.1% | ||
| Q3 25 | 5.7% | 4.7% | ||
| Q2 25 | 7.8% | 7.6% | ||
| Q1 25 | 8.6% | -5.3% | ||
| Q4 24 | 5.7% | 10.2% | ||
| Q3 24 | 8.9% | 7.6% | ||
| Q2 24 | 4.6% | 8.8% | ||
| Q1 24 | 7.6% | -1.9% |
资本支出强度EHCRHI
| Q4 25 | 14.8% | 0.9% | ||
| Q3 25 | 12.7% | 1.0% | ||
| Q2 25 | 10.8% | 1.1% | ||
| Q1 25 | 11.2% | 0.9% | ||
| Q4 24 | 14.1% | 1.0% | ||
| Q3 24 | 10.9% | 1.2% | ||
| Q2 24 | 12.1% | 0.8% | ||
| Q1 24 | 10.6% | 0.8% |
现金转化率EHCRHI
| Q4 25 | 2.37× | — | ||
| Q3 25 | 2.14× | 1.80× | ||
| Q2 25 | 1.90× | 2.91× | ||
| Q1 25 | 1.90× | -3.42× | ||
| Q4 24 | 2.31× | — | ||
| Q3 24 | 2.48× | 1.98× | ||
| Q2 24 | 1.91× | 2.08× | ||
| Q1 24 | 2.12× | -0.25× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
RHI
| Finance And Accounting | $535.2M | 41% |
| Protiviti | $479.0M | 37% |
| Technology | $156.4M | 12% |
| Permanent Placement Talent Solutions | $102.6M | 8% |
| Other | $29.2M | 2% |
